UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

BioReader: a text mining tool for performing classification of biomedical literature

BMC bioinformatics, 2019-02, Vol.19 (Suppl 13), p.57-57, Article 57

2019

Link zum Volltext

Verfügbarkeit prüfen

TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes

BMC bioinformatics, 2021-04, Vol.22 (Suppl 8), p.40-40, Article 40

2021

Link zum Volltext

Verfügbarkeit prüfen

Expression and splicing mediate distinct biological signals

BMC biology, 2023-10, Vol.21 (1), p.1-220, Article 220

2023

Link zum Volltext

Verfügbarkeit prüfen

cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies

Nature communications, 2022-03, Vol.13 (1), p.1698-1698, Article 1698

2022

Link zum Volltext

Verfügbarkeit prüfen

CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment

Oncoimmunology, 2022-12, Vol.11 (1), p.2115655-2115655

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival

Journal of neuro-oncology, 2018-05, Vol.137 (3), p.533-542

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status

Scientific reports, 2021-01, Vol.11 (1), p.2259-2259, Article 2259

2021

Link zum Volltext

Verfügbarkeit prüfen

Building flexible and robust analysis frameworks for molecular subtyping of cancers

Molecular oncology, 2024-03, Vol.18 (3), p.606-619

2024

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

BMC cancer, 2017-04, Vol.17 (1), p.278-278, Article 278

2017

Link zum Volltext

Verfügbarkeit prüfen

Using microarray‐based subtyping methods for breast cancer in the era of high‐throughput RNA sequencing

Molecular oncology, 2018-12, Vol.12 (12), p.2136-2146

2018

Link zum Volltext

Verfügbarkeit prüfen

Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial

Frontiers in immunology, 2020-11, Vol.11, p.595035-595035

2020

Link zum Volltext

Verfügbarkeit prüfen

Bioinformatics for cancer immunotherapy target discovery

Cancer Immunology, Immunotherapy, 2014-12, Vol.63 (12), p.1235-1249

2014

Link zum Volltext

Verfügbarkeit prüfen

High CD34 surface expression in BCP‐ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion

Molecular oncology, 2022-05, Vol.16 (10), p.2015-2030

2022

Link zum Volltext

Verfügbarkeit prüfen

Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer

Cancers, 2020-12, Vol.12 (12), p.3828

2020

Link zum Volltext

Verfügbarkeit prüfen

Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients

Molecular oncology, 2016-10, Vol.10 (8), p.1160-1168

2016

Link zum Volltext

Verfügbarkeit prüfen

Pronounced gut microbiota signatures in patients with JAK2V617F- positive essential thrombocythemia

Microbiology spectrum, 2023-09, Vol.11 (5), p.e0066223-e0066223

2023

Link zum Volltext

Verfügbarkeit prüfen

Algorithmic Clustering Of Single‐Cell Cytometry Data—How Unsupervised Are These Analyses Really?

Cytometry. Part A, 2020-03, Vol.97 (3), p.219-221

2020

Link zum Volltext

Verfügbarkeit prüfen

Characterizing the human hematopoietic CDome

Frontiers in genetics, 2014-09, Vol.5, p.331-331

2014

Link zum Volltext

Verfügbarkeit prüfen

A literature study and public survey on mass cytometry dataset release and reuse

Cytometry. Part A, 2022-02, Vol.101 (2), p.109-113

2022

Link zum Volltext

Verfügbarkeit prüfen

FluKB: A Knowledge-Based System for Influenza Vaccine Target Discovery and Analysis of the Immunological Properties of Influenza Viruses

Journal of immunology research, 2015-01, Vol.2015, p.380975-11

2015

Link zum Volltext

Verfügbarkeit prüfen

Conservation analysis of dengue virus T-cell epitope-based vaccine candidates using Peptide block entropy

Frontiers in immunology, 2011-01, Vol.2, p.69-69

2011

Link zum Volltext

Verfügbarkeit prüfen

An insulin hypersecretion phenotype precedes pancreatic β cell failure in MODY3 patient-specific cells

Cell stem cell, 2023-01, Vol.30 (1), p.38-51.e8

2023

Link zum Volltext

Verfügbarkeit prüfen

RNase H-dependent PCR-enabled T-cell receptor sequencing for highly specific and efficient targeted sequencing of T-cell receptor mRNA for single-cell and repertoire analysis

Nature protocols, 2019-08, Vol.14 (8), p.2571-2594

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(53)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(37)
Humans
(21)
Bioinformatics
(12)
Gene Expression
(12)
Oncology
(12)
Biochemistry & Molecular Biology
(10)
Immunology
(10)
Tumors
(9)
Antigens
(7)
Biochemical Research Methods
(7)
Immunotherapy
(7)
Software
(7)
Analysis
(6)
Cancer
(6)
Genetic Aspects
(6)
Hematology
(6)
Algorithms
(5)
Biotechnology & Applied Microbiology
(5)
Genomics
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

BioReader: a text mining tool for performing classification of biomedical literature

TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes

Expression and splicing mediate distinct biological signals

cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies

CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment

Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival

Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status

Building flexible and robust analysis frameworks for molecular subtyping of cancers

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

A Comparison of Tools for Copy-Number Variation Detection in Germline Whole Exome and Whole Genome Sequencing Data

Using microarray‐based subtyping methods for breast cancer in the era of high‐throughput RNA sequencing

Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial

Bioinformatics for cancer immunotherapy target discovery

High CD34 surface expression in BCP‐ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion

Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer

Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients

Pronounced gut microbiota signatures in patients with JAK2V617F- positive essential thrombocythemia

Algorithmic Clustering Of Single‐Cell Cytometry Data—How Unsupervised Are These Analyses Really?

Characterizing the human hematopoietic CDome

A literature study and public survey on mass cytometry dataset release and reuse

FluKB: A Knowledge-Based System for Influenza Vaccine Target Discovery and Analysis of the Immunological Properties of Influenza Viruses

Conservation analysis of dengue virus T-cell epitope-based vaccine candidates using Peptide block entropy

An insulin hypersecretion phenotype precedes pancreatic β cell failure in MODY3 patient-specific cells

RNase H-dependent PCR-enabled T-cell receptor sequencing for highly specific and efficient targeted sequencing of T-cell receptor mRNA for single-cell and repertoire analysis

Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib

Suchergebnisse filtern